Physician profile
Sergio Moreira
NPI 1790735918
$3,275.57
in general payments reported to CMS, 2019-2025
15 companies · $81.25 in 2025
The $81.25 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $169 · 2021: $82.01 · 2023: $2,398 · 2024: $283 · 2025: $81.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,217 · Travel and Lodging: $445 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,217.15 |
| Travel and Lodging | $444.93 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,161.89 | 2023-2025 | Interstim |
| Boston Scientific Corporation | $888.58 | 2019-2023 | Lithovue, Ams 700 Cxr Rte Kit |
| Intuitive Surgical, INC. | $527.52 | 2023 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $231.88 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $189.98 | 2019-2023 | |
| Axonics, INC. | $69.62 | 2023 | Axonics |
| Sumitomo Pharma America, INC. | $40.62 | 2023-2024 | Gemtesa |
| Coloplast Corp | $34.66 | 2023 | Altis, Speedicath |
| Teleflex LLC | $25.25 | 2023 | Urolift |
| Abbvie INC. | $20.28 | 2023 | |
| Endo Pharmaceuticals INC. | $18.73 | 2023 | Aveed, Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $18.42 | 2020 | |
| Ambu INC. | $17.12 | 2023 | |
| Abc Home Medical Supply, INC. | $16.02 | 2023 | |
| Pfizer INC. | $15.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Moreira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.